Darzalex (Daratumumab Vials) 20mg/ml x 5ml (100mg)

Daratumumab 20mg/ml x 5ml (100mg) vials are an injectable therapy used in certain blood cancers. This monoclonal antibody targets CD38 proteins on cancer cells. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance when using.

Strength

20mg/ml x 5ml (100mg)

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Jannsen - Cilag

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Daratumumab is primarily used to treat multiple myeloma, a type of blood cancer affecting plasma cells. It may also be used in combination with other therapies for newly diagnosed or relapsed conditions. Patients often ask, 'what is Daratumumab used for' in managing these specific cancer types. Always consult a healthcare professional for personalized treatment plans.

Side Effects

Daratumumab works by helping the immune system recognize and attack cancer cells. Patients may experience effects related to the immune response during treatment. These effects can vary widely between individuals and are typically monitored by a healthcare provider throughout therapy.

Precautions & Warnings

Keep vials refrigerated at 2-8°C and protect from light. Do not freeze or shake the vials. Always handle with care and follow aseptic techniques during preparation and administration. Dispose of used materials according to local regulations for medical waste.

Avoid Interactions

Daratumumab may interact with other medications that affect the immune system, such as immunosuppressants or live vaccines. Alcohol and certain herbal supplements could also interact; discuss all current medications with a healthcare provider. Monitoring is recommended when combining therapies to manage potential effects.

Frequently Asked Questions

Daratumumab is used to treat multiple myeloma, a blood cancer affecting plasma cells, often in combination with other therapies.

Daratumumab is given as an intravenous infusion by a healthcare professional in a clinical setting.

Common effects may include fatigue, nausea, or reactions related to the infusion process, which are typically monitored during treatment.

No, Daratumumab vials must be stored refrigerated between 2-8°C and protected from light.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.